MYP_125387
Basic Information
HR2-17
Antimicrobial
Antiviral
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
30 amino acids
C149H256N42O50
Standard
Sequence
VVNIQKEIDRLNEVAKNLNESLIDLQELGK
Physicochemical Analysis
3435.88 Da
4.66
-2.26
-2.48
-0.0752
-0.42
0.70
-0.10
49.10
136.33
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1549.75
-14.47
50.0
48.0
125.0
241.0
0.0
35.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0140712 VERIFIED: YES
Provenance & Taxonomy
Severe acute respiratory syndrome-related coronavirus [Virus]
Heptad repeat peptide
694009;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
SARS coronavirus (Virus entry); 293T
Luciferase assay
RECORD: Rec_0206608 VERIFIED: YES
Provenance & Taxonomy
Severe acute respiratory syndrome-related coronavirus [Virus]
HR2-derived fusion inhibitor
694009
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Severe acute respiratory syndrome coronavirus
EC50
RECORD: Rec_0389680 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 13.3%, E 0.0%, T 63.3%, C 23.3% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial